Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $13.66 billion. The enterprise value is $14.31 billion.
| Market Cap | 13.66B |
| Enterprise Value | 14.31B |
Important Dates
The next confirmed earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.04 million shares outstanding. The number of shares has increased by 5.20% in one year.
| Shares Outstanding | 70.04M |
| Shares Change (YoY) | +5.20% |
| Shares Change (QoQ) | -12.42% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 101.71% |
| Float | 69.68M |
Valuation Ratios
The trailing PE ratio is 58.57 and the forward PE ratio is 59.47. Insulet's PEG ratio is 3.15.
| PE Ratio | 58.57 |
| Forward PE | 59.47 |
| PS Ratio | 7.67 |
| Forward PS | 6.49 |
| PB Ratio | 17.28 |
| P/FCF Ratio | 122.40 |
| PEG Ratio | 3.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.94, with an EV/FCF ratio of 128.23.
| EV / Earnings | 61.15 |
| EV / Sales | 8.04 |
| EV / EBITDA | 40.94 |
| EV / EBIT | 52.02 |
| EV / FCF | 128.23 |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 1.77.
| Current Ratio | 3.74 |
| Quick Ratio | 2.48 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | 4.01 |
| Debt / FCF | 12.56 |
| Interest Coverage | 9.11 |
Financial Efficiency
Return on equity (ROE) is 34.90% and return on invested capital (ROIC) is 10.86%.
| Return on Equity (ROE) | 34.90% |
| Return on Assets (ROA) | 9.30% |
| Return on Capital (ROIC) | 10.86% |
| Revenue Per Employee | $593,567 |
| Profits Per Employee | $78,000 |
| Employee Count | 3,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, Insulet has paid $10.90 million in taxes.
| Income Tax | 10.90M |
| Effective Tax Rate | 4.45% |
Stock Price Statistics
The stock price has decreased by -32.24% in the last 52 weeks. The beta is 1.15, so Insulet's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -32.24% |
| 50-Day Moving Average | 190.50 |
| 200-Day Moving Average | 180.71 |
| Relative Strength Index (RSI) | 47.80 |
| Average Volume (20 Days) | 668,145 |
Short Selling Information
The latest short interest is 2.87 million, so 4.10% of the outstanding shares have been sold short.
| Short Interest | 2.87M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 4.10% |
| Short % of Float | 4.12% |
| Short Ratio (days to cover) | 3.68 |
Income Statement
In the last 12 months, Insulet had revenue of $1.78 billion and earned $234.00 million in profits. Earnings per share was $3.33.
| Revenue | 1.78B |
| Gross Profit | 1.23B |
| Operating Income | 249.20M |
| Pretax Income | 244.90M |
| Net Income | 234.00M |
| EBITDA | 349.50M |
| EBIT | 275.10M |
| Earnings Per Share (EPS) | $3.33 |
Balance Sheet
The company has $751.20 million in cash and $1.40 billion in debt, giving a net cash position of -$650.30 million or -$9.28 per share.
| Cash & Cash Equivalents | 751.20M |
| Total Debt | 1.40B |
| Net Cash | -650.30M |
| Net Cash Per Share | -$9.28 |
| Equity (Book Value) | 790.70M |
| Book Value Per Share | 11.29 |
| Working Capital | 1.19B |
Cash Flow
In the last 12 months, operating cash flow was $232.80 million and capital expenditures -$121.20 million, giving a free cash flow of $111.60 million.
| Operating Cash Flow | 232.80M |
| Capital Expenditures | -121.20M |
| Free Cash Flow | 111.60M |
| FCF Per Share | $1.60 |
Margins
Gross margin is 68.86%, with operating and profit margins of 13.99% and 13.14%.
| Gross Margin | 68.86% |
| Operating Margin | 13.99% |
| Pretax Margin | 13.75% |
| Profit Margin | 13.14% |
| EBITDA Margin | 19.63% |
| EBIT Margin | 15.45% |
| FCF Margin | 6.27% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.20% |
| Shareholder Yield | -5.20% |
| Earnings Yield | 1.71% |
| FCF Yield | 0.82% |
Analyst Forecast
The average price target for Insulet is $238.81, which is 22.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $238.81 |
| Price Target Difference | 22.45% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 15.73% |
| EPS Growth Forecast (5Y) | 18.46% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 5.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.86 |
| Piotroski F-Score | 7 |